Health Care & Life Sciences » Healthcare Provision | Falco Holdings Co. Ltd.

Falco Holdings Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
4,161
1,874
2,313
2,228
2,658
1,203
Depreciation, Depletion & Amortization
1,514
1,040
913
862
878
827
Other Funds
3,757
1,617
888
1,102
1,105
519
Funds from Operations
1,918
1,297
2,338
1,988
2,432
1,512
Changes in Working Capital
1,542
243
329
768
111
139
Net Operating Cash Flow
376
1,054
2,009
1,220
2,321
1,651
Capital Expenditures
1,185
705
491
1,679
905
Sale of Fixed Assets & Businesses
5,881
269
-
222
15
Purchase/Sale of Investments
415
1,512
405
240
347
Net Investing Cash Flow
4,358
1,282
874
1,802
615
Cash Dividends Paid - Total
295
399
413
427
445
Issuance/Reduction of Debt, Net
3,702
2,547
266
166
355
Net Financing Cash Flow
4,856
3,329
250
653
41
Net Change in Cash
122
991
881
1,235
1,664
Free Cash Flow
581
508
1,607
372
1,782
Other Sources
77
251
22
-
-
Change in Capital Stock
859
383
103
391
49
Exchange Rate Effect
-
2
4
-
1
Other Uses
-
45
-
104
72

About Falco Holdings Co.

View Profile
Address
346 Shimizu-cho
Kyoto Kyoto 604
Japan
Employees -
Website http://www.falco-hd.co.jp
Updated 07/08/2019
FALCO HOLDINGS Co., Ltd. engages in the provision of clinical testing and dispensing pharmacy services. It operates through the Clinical Testing and Dispensing Pharmacy segments. The Clinical Testing segment offers genetic testing, clinical research and trials, medical information technology, food hygiene, and environmental inspection services.